World's Best Scientists 2026 revealed!
Sophie D. Fosså

Sophie D. Fosså

Award Badge
Medicine
Norway
2026

D-Index & Metrics

Medicine

D-Index
135
Citations
70511
World Ranking
2066
National Ranking
6

Sophie D. Fosså publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Sophie D. Fosså sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,206 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Sophie D. Fosså D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Sophie D. Fosså sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 135 D-Index — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Medicine in Norway Leader Award
  • 2025 - Research.com Medicine in Norway Leader Award
  • 2023 - Research.com Medicine in Norway Leader Award
  • 2022 - Research.com Medicine in Norway Leader Award

Overview

Sophie D. Fosså is affiliated with Oslo University Hospital in Norway. Their research spans several areas within Medicine, with a strong focus on oncology and cancer survivorship. They have contributed extensively to studies related to prostate cancer, childhood cancer survivors, and treatment-related effects among long-term cancer patients.

Their main fields of study include Medicine, with significant contributions in the subfields of Pulmonary and Respiratory Medicine, Surgery, Oncology, Pediatrics, Perinatology and Child Health, as well as Public Health, Environmental and Occupational Health.

Key topics in Sophie D. Fosså's work cover:

  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Childhood Cancer Survivors' Quality of Life
  • Cancer survivorship and care
  • Testicular diseases and treatments
  • Family Support in Illness
  • Bladder and Urothelial Cancer Treatments

The scientist has published in multiple respected venues, including:

  • Journal of Clinical Oncology
  • Scandinavian Journal of Urology
  • Acta Oncologica
  • Supportive Care in Cancer
  • European Urology Open Science

Frequent collaborators include Tor Åge Myklebust, Alv A. Dahl, Cecilie E. Kiserud, Paul C. Dinh, and Patrick O. Monahan.

Among recent publications are:

  • Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14,324 women in 16 trials (2023, The Lancet)
  • Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: investigating dose-effect relationships in a European case-control study (PanCareLIFE) (2021, Human Reproduction)
  • Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy (2023, Journal of Clinical Oncology)
  • The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up (2020, European Heart Journal - Cardiovascular Imaging)
  • Self-reported late effects and long-term follow-up care among 1889 long-term Norwegian Childhood, Adolescent, and Young Adult Cancer Survivors (the NOR-CAYACS study) (2020, Supportive Care in Cancer)

Best Publications

  • Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

    C. Parker;S. Nilsson;S. Nilsson;D. Heinrich;S. I. Helle

  • International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers

    GM Mead;SP Stenning;P Cook;SD Fossa

  • Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history.

    Ragnhild A. Lothe;Paivi Peltomaki;Gunn Iren Meling;Lauri A. Aaltonen

  • Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial.

    Anders Widmark;Olbjørn Klepp;Arne Solberg;Jan Erik Damber

  • Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors

    Lois B. Travis;Sophie D. Fosså;Sara J. Schonfeld;Mary L. McMaster

  • Randomized Phase III Trial of High–Dose-Intensity Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (MVAC) Chemotherapy and Recombinant Human Granulocyte Colony-Stimulating Factor Versus Classic MVAC in Advanced Urothelial Tract Tumors: European Organization for Research and Treatment of Cancer Protocol No. 30924

    Cora N. Sternberg;P. H.M. De Mulder;J. H. Schornagel;C. Théodore

  • European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus group (EGCCCG): Part I

    Susanne Krege;Jörg Beyer;Rainer Souchon;Peter Albers

  • European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)

    H. J. Schmoll;R. Souchon;S. Krege;P. Albers

  • Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial

    Oliver Sartor;Robert E Coleman;Sten Nilsson;Daniel Heinrich

  • Extragonadal Germ Cell Tumors of the Mediastinum and Retroperitoneum: Results From an International Analysis

    Carsten Bokemeyer;Craig R. Nichols;Jean P. Droz;Hans J. Schmoll

  • Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study.

    Hanne Stensheim;Bjørn Møller;Tini van Dijk;Sophie D. Fosså

  • Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours.

    C.N. Sternberg;P.H.M. de Mulder;J.H. Schornagel;C. Theodore

  • First Clinical Experience with α-Emitting Radium-223 in the Treatment of Skeletal Metastases

    Sten Nilsson;Roy H. Larsen;Roy H. Larsen;Sophie D. Fosså;Lise Balteskard

  • Test/Retest Study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire

    Marianne Jensen Hjermstad;Sophie D. Fossa;Kristin Bjordal;Stein Kaasa

  • An international field study of the EORTC QLQ-PR25: A questionnaire for assessing the health-related quality of life of patients with prostate cancer

    George van Andel;Andrew Bottomley;Sophie D. Fosså;Fabio Efficace

  • Optimal Planning Target Volume for Stage I Testicular Seminoma: A Medical Research Council Randomized Trial

    Sophie D. Fossa;A. Horwich;J. M. Russell;J. T. Roberts

  • Interferon-alpha and survival in metastatic renal carcinoma: early results of a randomised controlled trial

    A Ritchie;G Griffiths;M Parmar;SD Fossa

  • Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up Study

    Hege S. Haugnes;Torgeir Wethal;Nina Aass;Olav Dahl

  • Anxiety, depression, and quality of life in caregivers of patients with cancer in late palliative phase

    E. K. Grov;A. A. Dahl;T. Moum;S. D. Fosså

  • Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's Lymphoma

    David C. Hodgson;Ethel S. Gilbert;Graça M. Dores;Sara J. Schonfeld

Frequent Co-Authors

Alv A. Dahl
Alv A. Dahl University of Oslo
Roy M. Bremnes
Roy M. Bremnes University of Tromsø - The Arctic University of Norway
Lawrence H. Einhorn
Lawrence H. Einhorn Indiana University
Alan Horwich
Alan Horwich Royal Marsden NHS Foundation Trust
Ragnhild A. Lothe
Ragnhild A. Lothe University of Oslo
Howard D. Sesso
Howard D. Sesso Harvard Medical School
Hans H. Storm
Hans H. Storm Danish Cancer Society
Per Hall
Per Hall Karolinska Institute
Heikki Joensuu
Heikki Joensuu University of Helsinki
Robert Huddart
Robert Huddart Institute of Cancer Research

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine opens doors to various educational routes beyond the traditional MD. Those interested in quickly entering healthcare may consider fast track lpn programs online, which prepare students to become Licensed Practical Nurses within a shorter timeframe.

For registered nurses aiming to advance their practice, bsn to np programs online offer a flexible path to becoming Nurse Practitioners in specialized fields like psychiatric mental health and more.

Not all medical careers involve direct patient care—some focus on managing systems and policies. Choosing an affordable healthcare administration degree online can equip you with essential leadership and operational skills for hospitals, clinics, or public health organizations.

Those ready to take on higher-level roles should explore affordable online mha programs, which provide comprehensive training in strategy and management tailored for modern healthcare environments.

Each of these pathways offers flexible, cost-effective options for building a rewarding career in the expanding field of healthcare.

Best Scientists Citing Sophie D. Fosså

Trending Scientists

Recently Published Articles